Sovihep 400 mg Tablet contains Sofosbuvir, an antiviral medication used to treat chronic hepatitis C virus (HCV) infection. Sofosbuvir is a direct-acting antiviral agent that inhibits the RNA polymerase enzyme essential for the replication of HCV. By interfering with this enzyme, Sofosbuvir reduces the viral load in the body and aids in clearing the infection.
Sovihep 400 mg Tablet is typically prescribed in combination with other antiviral medications, such as Ribavirin or Peginterferon alfa, depending on the specific HCV genotype and patient characteristics. The standard dosage is one tablet taken orally once daily, with or without food. Adherence to the full course of treatment is crucial to achieve optimal outcomes and prevent the development of drug-resistant virus strains.
Common side effects associated with Sovihep 400 mg Tablet include fatigue, headache, nausea, insomnia, and anemia. Most side effects are mild to moderate in severity. Patients should inform their healthcare provider of any existing medical conditions or other medications they are taking to avoid potential drug interactions. Regular monitoring of liver function and viral load is recommended during treatment to assess efficacy and detect any adverse effects promptly.
Sovihep 400 mg Tablet has significantly improved the management of chronic HCV infection, offering a higher cure rate and a shorter treatment duration compared to previous therapies. Consultation with a healthcare professional is essential to determine the most appropriate treatment regimen based on individual patient factors.
Reviews
There are no reviews yet.